Tuber/nodule burden, early electroencephalogram characteristics in newborns and infants, infantile spasms, and TSC2 mutation have been proposed as putative early biomarkers of a pharmacorefractory course [7–9]. This evidence concerns the gene TSC2 and infantile spasms.